Real-time enrollment status for this chronic spontaneous urticaria clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06555328 |
| Recruiting Status | Terminated |
| Condition | Chronic Spontaneous Urticaria |
| Phase | Clinical Trial |
| Target Enrollment | 75 participants |
| Active Locations | 9 sites in the US |
| Sponsor | InflaRx GmbH |
| Last Updated on CT.gov | February 3, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06555328 is currently terminated participants. This clinical trial study for chronic spontaneous urticaria is not currently accepting new participants at 9 locations across the United States. The study is sponsored by InflaRx GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06555328 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06555328 was last updated 3 weeks ago (February 3, 2026). HelloStudys verifies this status automatically.